The ruling comes against the backdrop of a mounting trauma burden in India, where nearly 4.67 lakh accidental deaths occur annually
Favorable outcome would contribute to significantly containing the Roundup litigation as the company continues its multi-pronged strategy
At the heart of the showdown is a deep split among federal circuit courts over whether federal law overrides state failure-to-warn claims in Roundup personal-injury suits
Company plans to appeal against CGST order related to alleged inadmissible input tax credit claims
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
RedHill has obtained a court-approved asset attachment in South Korea to prevent Kukbo from transferring or disposing of assets ahead of enforcement of the judgment
Bayer expects 2025 to be the most difficult year of its turnaround
Scientific consensus is that there is no consistent or reliable evidence that ranitidine increases the risk of any cancer and GSK will continue to vigorously defend itself against all claims
The judicial response to industry lawsuits on drug pricing regulations have been mixed in the past
In a time when conversations around mental health have become ever more urgent Vaidya’s work is extremely contextual
Subscribe To Our Newsletter & Stay Updated
